Kozak & Associates, Inc. Abbott Laboratories Transaction History
Kozak & Associates, Inc.
- $482 Million
- Q2 2025
A detailed history of Kozak & Associates, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Kozak & Associates, Inc. holds 1,006 shares of ABT stock, worth $131,806. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,006
Previous 1,002
0.4%
Holding current value
$131,806
Previous $132,000
3.03%
% of portfolio
0.03%
Previous 0.03%
Shares
15 transactions
Others Institutions Holding ABT
# of Institutions
3,580Shares Held
1.39BCall Options Held
9.73MPut Options Held
9.08M-
Vanguard Group Inc Valley Forge, PA173MShares$22.6 Billion0.39% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.2 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.7MShares$10.2 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA66.8MShares$8.76 Billion1.82% of portfolio
-
Capital Research Global Investors Los Angeles, CA50.7MShares$6.65 Billion1.53% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $229B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...